NCT06548802

Efficacy and Safety of Baricitinib in the Post-intracerebral Hemorrhage Pulmonary Injury

RecruitingPHASE1, PHASE2INTERVENTIONAL

Trial Details

Start: 2024-02-29Est. Completion: 2026-12-31

Enrollment target: 100 participants

Locations

Tianjin Medical University General Hospital, Tianjin, Tianjin Municipality, China

Cardiogenic Shock Post Myocardial Infarction

The aim of this trial is to evaluate whether a structured and time-optimized escalation strategy from a transfemoral mic…

Düsseldorf, GermanyEst. completion Oct 2028

Cardiogenic ShockAcute Myocardial Infarction (AMI)Heart Failure, Acute

The goal of this clinical trial is to learn which treatment strategies improve survival in adult patients with acute myo…

Leipzig, GermanyEst. completion Oct 2030

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.